Anthonius S. M. Dofferhoff

Author

Also Known As

A. S. M. Dofferhoff, A.S. M. Dofferhoff, A.S.M. Dofferhoff, Anthonius Dofferhoff, Anthonius S M Dofferhoff, Anthonius S. M. Dofferhoff, Anthonius S.M. Dofferhoff, H. J. M. ter Hofstede, K. van Aerde, Noortje L.Q. Schwandt

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Canisius-Wilhelmina Ziekenhuis Radboud University Medical Center University Medical Center Groningen Erasmus MC

About

Anthonius S. M. Dofferhoff is an author at Radboud University Nijmegen specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	573
2	Health Sciences	1	1	160
3	Public Health	1	1	237
4	Allergy	1	1	160
5	Epidemiology	1	1	42

Anthonius S. M. Dofferhoff

Publications

973

Citations

H-Index

Page 1

	Year	Citations
Convalescent Plasma for COVID-19. A randomized clinical trial Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel, VaccinationImmunohematologyStructured AbstractLong CovidNeutralizing Antibodies	2020	237
Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo Study Anthonius S. M. Dofferhoff, Jan Hendrik Nijland, H. G. de Vries-Hospers, Scandinavian Journal of Infectious Diseases Endotoxin ReleaseEscherichia ColiFree Endotoxin ReleaseFree EndotoxinAntimicrobial Chemotherapy	1991	160
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel, Nature Communications	2021	158
The release of endotoxin from antibiotic-treated <i>Escherichia coli</i> and the production of tumour necrosis factor by human monocytes Anthonius S. M. Dofferhoff, MT Esselink, H. G. de Vries-Hospers, Journal of Antimicrobial Chemotherapy	1993	78
Concentration-dependency of β-lactam-induced filament formation in Gram-negative bacteria J. Buijs, Anthonius S. M. Dofferhoff, Johan W. Mouton, Clinical Microbiology and Infection Gram-negative BacteriologyBacteriologyMicrobial PhysiologyMicrobiologyMolecular Microbiology	2008	71
Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience Steven Schalekamp, Chantal P. Bleeker‐Rovers, Ludo F.M. Beenen, Radiology	2020	60
Complement Activation and the Production of Inflammatory Mediators During the Treatment of Severe Sepsis in Humans Anthonius S. M. Dofferhoff, Hendrika J. de Jong, V J J Bom, Scandinavian Journal of Infectious Diseases Severe SepsisInnate Immune SystemImmunologyInflammationHematology	1992	42
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial Anne Boerekamps, Anja De Weggheleire, Guido E van den Berk, The Lancet. Gastroenterology & hepatology Acute Hepatitis CHepatologyHepatitis CViral HepatitisAntiviral Therapy	2019	42
Continuous administration of PBP-2- and PBP-3-specific β-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis Jacqueline Buijs, Anthonius S. M. Dofferhoff, Johan W. Mouton, Journal of Antimicrobial Chemotherapy	2007	25
Influence of Low Dose Ciprofloxacin on Microbial Colonization of the Digestive Tract in Healthy Volunteers During Normal and During Impaired Colonization Resistance Joris J. J. P. M. van de Leur, Ernst J. Vollaard, A. J. H. M. Janssen, Scandinavian Journal of Infectious Diseases	1997	22

Page 1